TrialPharmaceutical research2014
Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjects.
Lisa Felden et al.PubMed ↗Publisher ↗
No numbers read from the abstract.